Kieran Breen | Head Of Research And Development
European Medicines Agency

Kieran Breen, Head Of Research And Development, European Medicines Agency

Dr Kieran Breen had an academic career with a focus on Alzheimer’s disease research before working in research funding organisations where he developed new strategic research initiatives. He has served on the review boards for a number of research organisations and has been involved in the development and utilisation of patient data registries. He has been a member of the European Medicines Agency’s Committee for Advanced Therapies (CAT) since 2013 where has been involved in the assessment of new ATMPs as well as the provision of scientific advice for developing products, particularly in the non-clinical area. He represents the CAT on the cross-committee working party on patient registries as well as the Patient and Consumers Working Party.


Conference Day 2 - Wednesday 1st April 2020 @ 12:20

Panel discussion: Regulatory submissions: gathering the evidence

last published: 04/Jun/20 08:25 GMT

back to speakers